ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Fatigue"

  • Abstract Number: 0379 • ACR Convergence 2025

    Do Rheumatoid Arthritis Patients have Residual Fatigue Without Swollen Joints and Laboratory Inflammation? A Multicenter Study

    Rosa Maria Morlà Novell1, Enrique González-Dávila2, Beatriz Frade Sosa3, Maria López-Lasanta4, Noemí Busquets Pérez5, Marta Valls Roc6, Meritxell Sallés Lizarzáburu7, Georgina Salvador Alarcón8, Virginia Ruiz-Esquide9, Lola Tobalina Mastre10, José Gomez-Puerta11 and Raimon Sanmartí9, 1Hospital Clínic de Barcelona, Barcelona, Spain, 2Departamento de Matemáticas. Universidad de La Laguna, Tenerife, Spain, 3Hospital Clinic de Barcelona, Barcelona, Catalonia, Spain, 4Hospital Universitari Vall d´Hebron, Barcelona, Spain, 5Hospital de Granollers, Granollers, Spain, 6Hospital Universitari Dr Trueta, Girona, Sudan, 7Xarxa Sanitària Althaia Manresa, Manresa, Spain, 8Hospital Universitari Mùtua Terrassa, Terrassa, Spain, 9Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain, 10IDIBAPS. Hospital Clinic de Barcelona, Barcelona, 11Rheumatology Department, Hospital Clinic, Barcelona, Spain, Barcelona, Spain

    Background/Purpose: Residual fatigue highlights an unmet prevalent1 need in rheumatoid arthritis (RA) patients despite achieving remission of disease activity according to activity indices (DAS28).We examine…
  • Abstract Number: 2378 • ACR Convergence 2025

    Factors Associated With Fatigue In Systemic Lupus Erythematosus: Data From The Almenara Lupus Cohort

    Alvaro Oyarce-Calderón1, Rocío Gamboa-Cárdenas2, Victor Pimentel-Quiroz3, Samira Garcia-Hirsh4, Zoila Rodríguez-Bellido5, Cesar Pastor-Asurza6, Risto Perich-Campos7, Graciela Alarcón8 and Manuel Ugarte-Gil9, 1Hospital Nacional Guillermo Almenara Irigoyen, San Miguel, Lima, Peru, 2Universidad Científica del Sur, Lima, Peru, 3Universidad Científica del Sur, San Isidro, Peru, 4Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru, 5Hospital Nacional Guillermo Almenara Irigoyen; Universidad Nacional Mayor de San Marcos, Lima, Peru, 6Hospital Nacional Guillermo Almenara Irigoyen, Lima, Pakistan, 7Hospital Nacional Guillermo Almenara Irigoyen; Universidad Nacional Mayor de San Marcos, La Molina, Peru, 8The University of Alabama at Birmingham, Oakland, CA, 9Grupo Peruano de Estudio de Enfermedades Autoinmunes Sistémicas, Universidad Científica del Sur, Lima, Peru; Hospital Guillermo Almenara Irigoyen, EsSalud, Lima, Peru, Lima, Peru

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease characterized by a wide spectrum of clinical manifestations, fatigue being one of them; it is…
  • Abstract Number: 0295 • ACR Convergence 2025

    Multidimensional Analysis of Fatigue in Idiopathic Inflammatory Myopathies: Clinical, Psychological, and Sociodemographic Determinants

    Manali Sarkar1, Meera Shah2, Vincenzo Venerito3, Vikas Agarwal4 and Latika Gupta5, 1Sir H. N. Reliance Foundation Hospital and Research Centre, Mumbai, Maharashtra, India., Mumbai, Maharashtra, India, 2Indraprastha Apollo Hospital, New Delhi, Mumbai, Maharashtra, India, 3Univeristy of Bari "Aldo Moro", Italy, Bari, Bari, Italy, 4Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India, 5School of Infection, Inflammation and Immunology, College of Medicine and Health, University of Birmingham; Royal Wolverhampton NHS Trust; Centre for Musculoskeletal Research, School of Biological Sciences, The University of Manchester, Manchester; Francis Crick Institute, London, Birmingham, UK, United Kingdom

    Background/Purpose: Fatigue significantly impacts quality of life in idiopathic inflammatory myopathies (IIM) but remains poorly understood. This study aimed to identify the key determinants of…
  • Abstract Number: 2254 • ACR Convergence 2025

    Association of disease activity with insomnia, depression, and fatigue in patients with rheumatoid arthritis: a multicenter prospective observational study

    Misako Higashida-Konishi1, Keisuke Izumi2, Shuntaro Saito Saito3, Hiroki Tabata4, Satoshi Hama4, Tatsuhiro Oshige4, Yutaka Okano4, Hisaji Oshima4, Katsuya Suzuki4, Jiro Sakamoto5, Toshikazu Fukami5, Kazumichi Minato5, Nobuhiko Kajio6, Yasushi Kondo3, Hiroaki Taguchi6 and Yuko Kaneko3, 1NHO Tokyo Medical Center, Tokyo Meguroku, Japan, 2Division of Rheumatology, Department of Medicine, NHO Tokyo Medical Center/Keio University School of Medicine/TechDoctor, Inc., Tokyo, Japan, 3Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, 4Division of Rheumatology, Department of Medicine, NHO Tokyo Medical Center, Tokyo, Japan, 5TechDoctor, Inc., Tokyo, Japan, 6Department of Rheumatology, Kawasaki Municipal Hospital, Kanagawa, Japan

    Background/Purpose: Patients with rheumatoid arthritis (RA) often experience not only joint-related symptoms but also systemic issues such as insomnia, depression, and fatigue [1–3]. These symptoms…
  • Abstract Number: 0207 • ACR Convergence 2025

    The Feasibility and Clinical Effects of Anti-Inflammatory Diet Intervention In Patients Diagnosed With Long COVID (Post-Acute Sequelae of SARS CoV-2, PASC)

    Suzi Hong1, Marcos Monteon2, Kathleen Bundy3, Chloe Delgado Ramirez3, Phoebe Senowitz3, Monica Guma4, Nina Acebo5, Chris Pruitt6, Tanya Shekhtman3, Shahrokh Golshan7 and Susan Lee8, 1Herbert Wertheim School of Public Health and Human Longevity Science UCSD; Department of Psychiatry UCSD, San Diego, 2University of California, San Diego, San Diego, 3Department of Family Medicine, Center for Integrative Health, Krupp Endowment Fund, UCSD, La Jolla, 4University of California San Diego, San Diego, CA, 5University of California, San Diego, La Jolla, 6Herbert Wertheim School of Public Health and Human Longevity Science, UCSD, La Jolla, 7Department of Pyschiatry, UCSD, La Jolla, 8Department of Medicine, University of California, San Diego, La Jolla, CA

    Background/Purpose: There have been over 777 million cases of acute COVID-19 infections worldwide as of April 2025. Although many patients recover, an estimated 10-30% of…
  • Abstract Number: 1854 • ACR Convergence 2025

    Resting-State Functional Magnetic Resonance Imaging Analysis Revealed Altered Functional Connectivity Associated with Fatigue in Systemic Lupus Erythematosus

    Yujie Song1, Nobuya Abe1, Yuichiro Fujieda2, Kodai Sakiyama1, Yuta Inoue1, Kenichi Miyamoto1, Kazuro Kamada1, Yotaro Oki1, Maria Tada1, Shuhei Takeyama1, Ryo Hisada2, Michihito Kono2 and Tatsuya Atsumi2, 1Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan, 2Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan

    Background/Purpose: Fatigue is one of the most frequent constitutional symptoms in systemic lupus erythematosus (SLE), usually accompanied with impaired quality of life. Resting-state functional magnetic…
  • Abstract Number: 1711 • ACR Convergence 2025

    Dysfunctional Neurobiology Of The Insula Characterizes Fatigue In Psoriatic Arthritis

    Andrew McGucken1, Flavia Sunzini2, Kristian Stefanov1, Joel Parkinson1, Salim Al-Wasity1, John McLean1, Gordon Waiter3, Stefan Siebert1 and Neil Basu4, 1University of Glasgow, Glasgow, United Kingdom, 2Glasgow University, Glasgow, United Kingdom, 3University of Aberdeen, Aberdeen, United Kingdom, 4Institute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, United Kingdom

    Background/Purpose: Fatigue is a pervasive and burdensome symptom for people with psoriatic arthritis (PsA). The mechanisms underlying PsA related fatigue are unknown. In other clinical…
  • Abstract Number: 1937 • ACR Convergence 2024

    Wellness and Burnout Among Pediatric Rheumatologists in North America- A 2024 CARRA Study

    Kathryn Cook1, Aviya Lanis2, Arielle Hay3, Daniel Glaser4, Sarah Hoffmann5, Lakshmi Moorthy6, Onengiya Harry7, Deepika Singh8 and Sheetal Vora9, and for the CARRA Investigators, 1Akron Children's Hospital, Akron, OH, 2Seattle Children's Hospital, Seattle, WA, 3Nicklaus Children's Hospital, Hollywood, FL, 4Yale University School of Medicine, New Haven, CT, 5Children's Hospital of Richmond at VCU, Richmond, VA, 6Rutgers Robert Wood Johnson Medical School, Metuchen, NJ, 7Brenner Children's Hospital - Wake Forest Baptist Health, Winston-Salem, NC, 8Valley Children's Healthcare, Clovis, CA, 9Atrium Health Levine Children's Hospital, Charlotte, NC

    Background/Purpose: A high proportion of pediatricians experience burnout symptom impacting patient care and academic productivity. Burnout is a state of physical, emotional or mental exhaustion…
  • Abstract Number: 2002 • ACR Convergence 2024

    Pain and Physical Function, but Not Fatigue, Track with Disease Activity in Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis

    Laura Cappelli1, Cyd Eaton1, Yunzhi Wang1, Michelle Jones2 and Clifton Bingham3, 1Johns Hopkins School of Medicine, Baltimore, MD, 2Johns Hopkins School of Medicine, Pittsburgh, PA, 3Johns Hopkins University, Baltimore, MD

    Background/Purpose: Immune checkpoint inhibitor-induced inflammatory arthritis (ICI-IA) is an impactful and often persistent side effect of cancer immunotherapy that can lead to permanent joint damage…
  • Abstract Number: 2029 • ACR Convergence 2024

    Iron Deficiency in Familial Mediterranean Fever: A Study on 211 Adult Patients from the JIR Cohort

    Ilenia Di Cola1, Lea Savey2, Marion Delplanque3, Rim bourguiba3, Alessandra Bartoli4, Zohra Aknouche3, Fatima Bensalek3, Isabelle Kone Paut5, Linda Rossi Semerano5, Isabelle Melki6, Brigitte Bader-Meunier7, Bénédicte Neven6, PIERRE QUARTIER8, Guilaine Boursier9, Irina Giurgea10, Laurence Cuisset11, Gilles Grateau3, Veronique Hentgen12 and Sophie Georgin-lavialle13, 1University of L'Aquila, L'Aquila, Italy, 2Internal Medicine Department, Tenon Hospital, AP-HP, Paris, France, france, France, 3Internal Medicine Department, Tenon Hospital, AP-HP, Paris, France, Paris, France, 4Internal Medicine Department, Tenon Hospital, AP-HP, Paris, France, italy, Italy, 5Kremlin Bicêtre hospital, Le Kremlin Bicêtre, France, 6Necker Hospital, Paris, France, 7Necker Hospital, Assistance Publique Hopitaux de Paris, Paris, France, 8Université Paris-Cite, IMAGINE Institute, Necker Children’s Hospital, Paris Cedex 15, France, 9University of Montpellier, Montpellier, 10Trousseau hospital, Paris, France, 11Cochin hospital, Paris, France, 12Laboratoire de Génétique des Maladies Rares et Autoinflammatoires, Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, CEREMAIA, CHU de Montpellier, Univ Montpellier, Montpellier, France, Le Chesnay, France, 13Sorbonne Université, Department of internal medicine, Tenon Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France

    Background/Purpose: Familial Mediterranean fever (FMF) is the most common monogenic autoinflammatory disease worldwide. Fatigue is known to trigger FMF attacks. So far, no association has…
  • Abstract Number: 2225 • ACR Convergence 2024

    Role of Fatigue in Difficult to Treat Rheumatoid Arthritis

    Maria Rodriguez-Laguna1, Leticia Leon2, Dalifer Freites Nuñez3, Cristina Hormigos-martin4, jose otazu Moudelle4, Alfredo Madrid García5, Benjamin fernandez-Gutierrez2 and lydia Abasolo Alcazar6, 1Resident in Rheumatology, Madrid, Spain, 2Hospital Clinico San Carlos, Madrid, Spain, 3Hospital Clínico San Carlos. Madrid. Spain., Madrid, Spain, 4Hospital Clínico San Carlos, madrid, Spain, 5Fundación para la Investigación Biomédica del Hospital Clínico San Carlos (IDISCC), Madrid, Madrid, Spain, 6IdISSC. HCSC, Madrid, Spain

    Background/Purpose: A subset of patients with rheumatoid arthritis (RA) who remains symptomatic after failing to multiple therapies are deemed to have "difficult-to-treat" (D2T RA). Fatigue…
  • Abstract Number: 0357 • ACR Convergence 2024

    Evaluating Meaningful Within-Person Change Thresholds in PROMIS-Fatigue Scores from Three Phase 3 Clinical Trials of Sarilumab for Rheumatoid Arthritis Using Empirical Cumulative Distribution Function (eCDF) Curves

    Clifton Bingham1, Emily Molina2, Amy Praestgaard3, Stefano Fiore3 and David Cella4, 1Johns Hopkins University, Baltimore, MD, 2Johns Hopkins, Baltimore, MD, 3Sanofi, Bridgewater, NJ, 4Northwestern University, Chicago, IL

    Background/Purpose: To evaluate changes over time in fatigue measured by Patient Reported Outcome Measures Information System (PROMIS)-Fatigue scores in rheumatoid arthritis (RA) patients treated with…
  • Abstract Number: 2368 • ACR Convergence 2024

    Bimekizumab-Treated Patients with Active Psoriatic Arthritis Showed Sustained Improvements in Pain and Fatigue: Up to 2-Year Results from Two Phase 3 Studies

    Philip Mease1, William Tillett2, Maarten de Wit3, Laure Gossec4, M. Elaine Husni5, Fabian Proft6, Barbara Ink7, Rajan Bajracharya7, Jason Coarse8, Jérémy Lambert9, Laura Coates10 and Alice Gottlieb11, 1Swedish Medical Center/Providence St. Joseph Health; University of Washington School of Medicine, Seattle, WA, 2Royal National Hospital of Rheumatic Diseases; Department of Life Sciences, Centre for Therapeutic Innovation, University of Bath, Bath, United Kingdom, 3Stichting Tools, Patient Research Partner, Amsterdam, Netherlands, 4Sorbonne Université, Paris, France, 5Cleveland Clinic, Cleveland, OH, 6Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, 7UCB Pharma, Slough, United Kingdom, 8UCB Pharma, Morrisville, NC, 9UCB Pharma, Colombes, France, 10University of Oxford, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford, United Kingdom, 11Icahn School of Medicine at Mount Sinai, Department of Dermatology, Seattle, WA

    Background/Purpose: PsA significantly impacts patients' quality of life due to functional limitations, pain, and fatigue.1 Sustained relief from pain and fatigue are therefore important aims…
  • Abstract Number: 0358 • ACR Convergence 2024

    Residual’ Fatigue and Its Severity in Patients with Rheumatoid Arthritis in Clinical Remission: Prevalence and Associated Factors

    Rosa Maria Morlà Novell1, Beatriz Frade-Sosa2, Lola Tobalina Maestre3, Meritxell Sallés Lizarzaburu4, Virginia Ruiz-Esquide2, Maria López Lasanta5, Georgina Salvador Alarcón6, Noemí Busquets Pérez7, Marta Valls Roc8, Enrique Gonzalez Dávila9, Jose Alfredo Gomez-Puerta10 and Raimon Sanmartí Sala10, and ARCat study Group, 1Hospital Clínic de Barcelona, Barcelona, Spain, 2Hospital Clinic de Barcelona, Barcelona, Spain, 3Fundació Clinic per la Recerca clínica, Barcelona, Spain, 4Althaia Xarxa Assistencial Universitària Manresa, Manresa, Catalonia, Spain, 5Hospital Universitari Vall d´Hebron, Rheumatology, Barcelona, Spain, 6Hospital Mútua de Terrassa, Terrassa, Spain, 7HOSP. GENERAL DE GRANOLLERS, GRANOLLERS, Spain, 8Hospital Universitari Josep Trueta, Girona, 9Universidad de La Laguna, Santa Cruz de Tenerife, Spain, 10Rheumatology Department, Hospital Clinic of Barcelona, Barcelona, Spain

    Background/Purpose: Fatigue is a frequent and annoying symptom in rheumatoid arthritis (RA) patients that is often not assessed at routine follow-up visits. Residual’ fatigue has…
  • Abstract Number: 2408 • ACR Convergence 2024

    Impact of Pain and Fatigue on Quality of Life Among Patients with Systemic Lupus Erythematosus

    Amanda Eudy1, Megan Clowse2, Meenakshi Jolly3, David Pisetsky4, Kai Sun5, Rebecca Sadun5, Lisa Criscione-Schreiber6, Mithu Maheswaranathan6, Jayanth Doss5 and Jennifer Rogers6, 1Duke University, Raleigh, NC, 2Duke University, Chapel Hill, NC, 3Rush University Medical Center, Chicago, 4Duke University Medical Center, Durham, NC, 5Duke University, Durham, NC, 6Duke University, Durham

    Background/Purpose: Our prior qualitative work discovered a subgroup of patients with SLE who experience persistent symptoms of fatigue and widespread pain, even on self-described “good…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 16
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology